Blocking specific glutamate receptors was seen to improve cellular, motor, and cognitive skills in a mouse model of Huntington’s disease.
José Lopes, PhD
José holds a PhD in neuroscience from the University of Porto, Portugal. After postdocs at Weill Connell Medicine and Western University, where he studied the processes driving hypertension and Alzheimer’s disease, he moved on in 2016 to a career in science writing and communication. José is the author of several peer-reviewed papers and a book chapter and has presented his research in numerous international meetings.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by José Lopes, PhD
Exercise and physical activity may benefit patients with Huntington’s disease (HD), a new review study shows. The study, “Physical…
Huntington’s disease (HD) patients respond to endurance training much like anyone else, by increasing muscular energy metabolism, say Swiss researchers…
Researchers have found that bexarotene, an existing, approved drug used to treat cancer, may also be an effective therapy…
uniQure recently showed that its gene therapy candidate AMT-130 improves motor coordination and survival in mouse models of…